Novo said total prescriptions for the Wegovy pill have now exceeded 2 million since its January launch, including 1.3 million prescriptions during the first quarter alone
Clinical Trial Results: What the Data Shows Semaglutide has been evaluated in the STEP (Semaglutide Treatment Effect in People with obesity) trial program, which included four major studies of semaglutide 2.4 mg weekly across different patient populations, including adults with obesity, adults with type 2 diabetes, and adults receiving intensive behavioral support alongside the medication
Originally developed for diabetes, GLP-1RAs have become a lifeline for millions seeking effective, sustainable weight loss solutions.
Compounded tirzepatide is a type of compounded drug that we offer
But the amount of weight you lose and the speed you lose it may leave much to be desired
At the Transformations Center for Weight Loss, we prioritize treatments that may give you the best results